A regularly updated video series answering a selection of frequently asked investor questions
January 27, 2020
Dry AMD Competitive Landscape Overview & OpRegen Positioning
December 31, 2019
Review of cost efficient business model & plans for 2020
December 17, 2019
Review of recent results from OpRegen Phase I/IIa study
Key opinion leaders discuss topics related to Lineage’s clinical programs
Why is dry age-related macular degeneration (dry AMD) research so important?
Allen C. Ho, M.D., Wills Eye Hospital Director of Retina Research
Why is spinal cord research so important?
Dr. John Steeves, Emeritus Principal Investigator @ICORD and Professor @UBC
Videos and interviews from specific events, conferences, or showcases
Solebury Trout Talks
Lineage Cell Therapeutics, Inc. (NYSE American: LCTX)
NameTag Series – Feb. 7th, 2020
Lineage Cell CEO encouraged about its dry AMD data
CEO Brian Culley chats with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco
H.C.Wainwright & Co. Annual Global Investment Conference
Lineage Cell Therapeutics, Inc. (NYSE American: LCTX)
Investor Presentation Sep 18th 2019